CHA Health Systems
Industry: Biotech and Life Science
CHA Health Systems (CHS) is a Korean biotechnology company that acquired Hollywood Presbyterian Medical Center in 2004, establishing the only Korean-owned and operated general hospital in the U.S. This location takes advantage of the leading biotech and life science R&D hubs and resources throughout California. The medical center broke ground on a new five-story patient tower in May 2018.
CHS is a leader in the biotechnology industry and is known for its research and clinical work in the field of therapies using cord blood stem cells and immune cells. CHS continues to develop and invest in advanced healthcare worldwide. CHS consists of 25 hospitals and clinics, 30 research facilities, 14 education institutions, and 30 bio/pharmaceutical/healthcare companies.
Find them online at: hollywoodpresbyterian.com